Search

everythinglearnresearchcommunity

for

Search:↓

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

No treatment fully prevents hair loss from chemotherapy yet.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Hair follicles prevent NK cell attacks to avoid hair loss.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

The treatment using a special hydrogel shows promise for promoting hair growth.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Interleukin-15 can help hair growth and protect hair follicles.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

The developed system could effectively treat hair loss and promote hair growth.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

TLR4 is important in aging-related diseases and could be a new treatment target.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The new drug delivery system effectively targets lung cancer cells.